RHÖN-KLINIKUM Aktiengesellschaft: Annual General Meeting approves all agenda items

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): AGM/EGM/AGM/EGM
RHÖN-KLINIKUM Aktiengesellschaft: Annual General Meeting approves all agenda items
07.06.2023 / 15:10 CET/CEST
The issuer is solely responsible for the content of this announcement.

Corporate News

Bad Neustadt a. d. Saale | 7 June 2023

Annual General Meeting approves all agenda items

RHÖN-KLINIKUM AG, one of the largest healthcare providers in Germany, today held its 35^th Annual General Meeting. The shareholders met virtually.

The shareholders of the Company reaffirmed their trust in the Board of Management and the Supervisory Board and gave their approval to all items of the agenda by a large majority. The dividend distribution totals 0.15 euro per no-par value share with dividend entitlement.

In his report, Prof. Tobias Kaltenbach, chairman of the Board of Management of RHÖN-KLINIKUM AG, set out the development of the Company and the future challenges ahead. “For 2022 also, RHÖN-KLINIKUM AG can look back on a financially sound, albeit challenging financial year and has made a good start into 2023 – despite difficult conditions in the hospital sector and the economy as a whole. We have implemented many structural measures and further expanded our care offering, above all in the outpatient area.“

RHÖN-KLINIKUM AG’s strategic tasks continue to be the following areas of action: concentrating on its core activities, expanding outpatient care structures, optimising processes, expanding digital structures and offerings, as well as strengthening nursing and medical care.

The voting results and the report of the Board of Management on today’s Annual General Meeting are available at https://en.rhoen-klinikum-ag.com/agm.

You can find the 2022 Annual Report at: https://en.rhoen-klinikum-ag.com/annual-report

RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. The hospitals offer excellent medical care with a direct tie-in to universities and research facilities. Each year some 855,000 patients are treated at our five sites of Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen and Universitätsklinikum Marburg (UKGM) as well as Zentralklinik Bad Berka. The Company employs over 18,100 persons. The innovative RHÖN Campus approach for cross-sector and future-oriented healthcare delivery in rural areas, the steadfast continuation of the gradual digital transformation within the Company as well as the strategic partnership with Asklepios are important elements of our corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.   www.rhoen-klinikum-ag.com

Contact:

RHÖN-KLINIKUM AG |Head of Corporate Finance, Treasury, Investor Relations and Sustainability
Julian Schmitt |T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Corporate Communications
Heike Ochmann | T. +49 9771 65-12130 | heike.ochmann@rhoen-klinikum-ag.com

 
RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale

07.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com